passages.id: split_1_test_2277_passage
passages.type: progene_text
passages.text: Genetics Institute had commenced a 150 - patient phase II trial for mild - to - moderate CD and mucositis and the company planned to file regulatory procedures for the indication of CD in 1999 [ 271210 ] .